Moreover, analysis of the Cancer Genome Atlas database by GEPIA revealed that RAB26 is significantly higher in NSCLC tissue compared with normal tissue (Fig. S2A), we therefore selected RAB26 for further validation. This evidence concerns the gene RAB26 and non-small cell lung carcinoma.